We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Use of angiotensin converting enzyme inhibitors in patients receiving therapeutic plasma exchange with a centrifuge‐based apheresis system.
- Authors
Jang, Soo Min; Bahjri, Khaled; Lee, Joanna; Nabavi, Sanaz; Abdipour, Amir
- Abstract
Angiotensin‐converting enzyme inhibitors (ACEi) are frequently used antihypertensive medications with additional advantages such as reducing proteinuria and cardiovascular events. ACEi are commonly held at least 24 hours before a therapeutic plasma exchange (TPE) to reduce possibility of adverse events (AEs) including adverse drug reactions (ADR). The objective of this study was to determine if ACEi use increases the risk of ADR in patients receiving TPE with a conventional centrifuge‐based apheresis system. This is a retrospective chart review study (n = 252; 52% male). Binary logistic regression was used to analyze the association of ACEi use and AEs. Of 171 patients who had AE during TPE, only 38 patients were taking ACEi. There was no significant association between ACEi use and AEs after adjustments (odds ratio = 0.885, 95% confidence interval: 0.468, 1.674). Our results suggest that risk of AEs is not higher in patients taking ACEi receiving TPE using a centrifuge‐based machine. Randomized controlled prospective trials may be needed to further investigate this matter.
- Subjects
ACE inhibitors; PLASMA exchange (Therapeutics); DRUG side effects; ANTIHYPERTENSIVE agents; RANDOMIZED controlled trials
- Publication
Therapeutic Apheresis & Dialysis, 2021, Vol 25, Issue 4, p497
- ISSN
1744-9979
- Publication type
Article
- DOI
10.1111/1744-9987.13589